PubMed's interface has been redesigned and the new interface has been released. You can access the 'new' PubMed via Himmelfarb Library's link which also incorporates links to Himmelfarb Library's full-text holdings and Himmelfarb's custom clinical/EBM limits to help users assess their search results.

PubMed's redesigned interface is geared toward simplicity and was retooled with the goal of making PubMed easier to use. While PubMed's search algorithms and search processing, including MeSH term mapping, remain unchanged, the search interface and screens are quite different. Some highlights of PubMed's redesign include:

• New header, search bar, and footer which are common to all PubMed pages.
• Advanced Search allows you to view your search history, search by field (e.g. author, journal, etc.), and limit your search (e.g. by full-text availability, language, article type, etc.).
• Links to related information are displayed along the right side of the search results screen including article titles containing your search terms; articles freely accessible on PubMed Central; related information from other NCBI databases; and your recent PubMed searches.
• Links to Himmelfarb Library's full-text journal collection are displayed on the upper-right portion of the screen.
• Each article includes an expandable area for publication types, MeSH terms, and substances which are hyperlinked for immediate searches or which can be used to build a more complex search strategy.

To coincide with the debut of PubMed's redesigned interface, Himmelfarb Library has integrated several new limits into PubMed to help you identify high-quality clinical information. These limits will display in the upper-right of the search results screen. The goal of these limits is to reduce your search time for high-quality evidence in order to allow you to maximize your time for reading and analyzing the available information. The new limits are:

• Clinical Reviews/EBM - limits articles to systematic reviews, practice guidelines, and meta-analyses, written in English.
• Clinical Trials - limits articles to controlled clinical trials, multicenter studies, and randomized controlled trials, written in English.
• Reviews - this tab contains review articles, written in English.

Additional resources:

• PubMed Quick Start
• PubMed Tutorials
• PubMed FAQs

Himmelfarb Library is currently offering trial access to two point-of-care information tools to the GWUMC community. Each of these tools, DynaMed and Epocrates Online Premium, has a mobile (PDA/Smartphone) component which faculty, residents, and students can test and assess in addition to the desktop access.

DynaMed

• Institutional subscription includes download for residents, faculty, and students at no additional charge.
• Compatible devices and download instructions.
• Email mlblea@gwumc.edu to request serial number for installation.
• Note: download the complete DynaMed rather than the version marked 'Trial'.

Epocrates Online Premium

• Institutional subscription does not include mobile download but group discount may be available to users who wish to purchase Epocrates Essentials, if this product is selected for licensing by Himmelfarb Library.
• Download available for 30-day trial.
• Compatible devices
• Download Instructions
• Email mlblea@gwumc.edu to request license code for free 30-day trial.
• Create Epocrates account then click to activate license code.

As with the desktop versions of DynaMed and Epocrates Online Premium, Himmelfarb Library invites you begin using the mobile counterparts in clinical care and let us know how well they work for you. We are particularly interested in hearing your feedback on content, evidence, and interface.

Please submit your feedback to Laura Abate at mlblea@gwumc.edu or 202-994-8570.

Health Care Fraud, a new analysis published by The George Washington University School of Public Health and Health Services, Department of Health Policy, in collaboration with the National Academy for State Health Policy, finds that health care fraud poses a major challenge in both the private and public insurance sectors and recommends policies aimed at assuring uniform and transparent measurement and reporting of fraud across all forms of coverage.

"A critical problem under current policy is the absence of ongoing and reliable fraud estimates similar to those available in the case of public health insurers," said lead author Sara Rosenbaum, Harold and Jane Hirsh Professor of Health Law and Policy and Chair of the Department. "As a result, it is difficult to fashion consistent policies to address fraud, a critical component of health reform."

The report also finds that fraud information related to public programs is frequently confused with payment error data. "While payment errors represent a major area for program improvement," Rosenbaum notes, "it is essential to separate such errors from actual instances of fraud, since the two problems call for distinct corrective strategies."

This report is issued as Congress considers steps to strengthen the tools and resources available to law enforcement to investigate and prosecute fraud, and as states focus increased attention on this problem.

In reviewing extensive data on health care fraud, the analysis points to evidence that fraud can emanate from the insurance industry itself. This finding is underscored by recent court decisions as well as by New York State's recent prosecution of multiple insurers for fraud in connection with provider claims payments as part of their administration of private insurance products and employee health benefit plans.

This report was funded with a Grant from the Robert Wood Johnson Foundation.

Resources

• Health Care Fraud
• Health Insurance Fraud: An Overview

Himmelfarb Library is pleased to offer you the opportunity to survey a trial of Journal Watch. Journal Watch reviews over 180 scientific and medical journals to present important clinical research findings and insightful commentary.

The following specialties are available as a part of this trial: Aids Clinical Care; Cardiology; Dermatology; Emergency Medicine; Gastroenterology; Infectious Diseases; Neurology; Oncology and Hematology; Pediatrics & Adolescent Medicine; Psychiatry; and Women's Health. Journal Watch has also made available an Audio Service, which features Expert Interviews; Clinical Conversations; and the specialty of General Medicine.

You can access Journal Watch content through the Himmelfarb Library Electronic Journals webpage. The trial period runs from now through November 31, 2009. If you have questions or comments, please contact Serials Librarian Steven Brown at mlbswb@gwumc.edu.

Himmelfarb Library will modify its hours over the Thanksgiving holiday weekend as listed below:

• Wednesday, November 25 7:30 AM - 8:00 PM
• Thursday, November 26 CLOSED
• Friday, November 27 CLOSED
• Saturday, November 28 9:00 AM - 8:00 PM
• Sunday, November 29 Open at 9:00 AM and regular (24/7) hours resume

PubMed has been redesigned and a new interface will be released soon. Currently, you can preview the redesign to get a feel for the new interface and also see some customizations which Himmelfarb Library has added.

PubMed's redesigned interface is geared toward simplicity with the goal of making PubMed easier to use. PubMed's search algorithms and search processing, including MeSH term mapping, remain unchanged. Some highlights of PubMed's redesign include:

• New header, search bar, and footer which are common to all PubMed pages.
• Advanced Search allows you to view your search history, search by field (e.g. author, journal, etc.), and limit your search (e.g. by full-text availability, language, article type, etc.).
• Links to related information are displayed along the right side of the search results screen including article titles containing your search terms; articles freely accessible on PubMed Central; related information from other NCBI databases; and your recent PubMed searches.

Himmelfarb Library has also integrated several new limits into PubMed to help you identify high-quality clinical information. These limits will display in the upper-right of the search results screen. The goal of these limits is to reduce your search time for high-quality evidence in order to allow you to maximize your time for reading and analyzing the available information. The new limits are:

• Clinical Reviews/EBM - limits articles to systematic reviews, practice guidelines, and meta-analyses, written in English.
• Clinical Trials - limits articles to controlled clinical trials, multicenter studies, and randomized controlled trials, written in English.
• Reviews - this tab contains review articles, written in English.

For more information on PubMed's redesign, please consult the NLM Technical Bulletin or watch Webcast: 2009 PubMed® Redesign.

During the next six months, Himmelfarb Library invites GWUMC faculty, students, and staff to evaluate two point-of-care information tools.

DynaMed

Epocrates Online Premium

Each of these information tools contains both drug and disease information. We invite you to begin using these tools in clinical care and let us know how well they work for you. We are particularly interested in hearing your feedback on:

• Content. Can you find the information that you need? Does the resource cover the topics that you need?
• Evidence. Can you determine the strength or level of evidence? Can you locate citations/links to the original research or references?
• Usability. Is the resource easy to navigate? Does the search work well for your topics? Can you navigate through the product easily?

Both resources are available from on-campus (including GW Hospital) and off-campus locations. From off-campus locations, you can login using either VPN/GWireless or ALADIN; for more information please consult Himmelfarb Library's off-campus access instructions.

As the trials progress, we will provide additional information on the resources and conduct focus groups to discuss each resource's advantages and disadvantages. If you have questions or comments, please contact Laura Abate at mlblea@gwumc.edu or 202-994-8570.